ENALAPRIL |
VASERETIC |
LEXXEL |
VASOTEC |
C09AA02 |
(S)-1-(N-(1-(ETHOXYCARBONYL)-3-PHENYLPROPYL)-L-ALANYL)-L-PROLINE |
EPL753 |
ENALAPRILUM |
1-(N-((S)-1-CARBOXY-3-PHENYLPROPYL)-L-ALANYL)-L-PROLINE 1'-ETHYL ESTER |
(S)-1-{(S)-2-[1-((S)-ETHOXYCARBONYL)-3-PHENYL-PROPYLAMINO]-PROPIONYL}-PYRROLIDINE-2-CARBOXYLIC ACID |
ENALADEX® |
ENALAPRILA |
ANALAPRIL |
VASOTEC® |
chembl:CHEMBL578 |
chemidplus:75847-73-3 |
rxcui:3827 |
pubchem.compound:5388962 |
drugbank:00584 |
Drug Categories | antihypertensive agents |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | antihypertensive agent |
Drug Class | antihypertensive agents |
Year of Approval | 1985 |
Drug Categories | ace inhibitors and calcium channel blockers |
Drug Categories | agents causing angioedema |
Drug Categories | agents causing hyperkalemia |
Drug Categories | agents causing muscle toxicity |
Drug Categories | antihypertensive agents indicated for hypertension |
Drug Categories | cytochrome p-450 cyp3a substrates |
Drug Categories | cytochrome p-450 substrates |
Drug Categories | decreased blood pressure |
Drug Categories | drugs causing inadvertant photosensitivity |
Drug Categories | oat1/slc22a6 inhibitors |
Drug Categories | oat3/slc22a8 inhibitors |
Drug Categories | oatp1b1/slco1b1 substrates |
Drug Categories | p-glycoprotein inhibitors |
Drug Categories | photosensitizing agents |
inhibitor (inhibitory) |
Specific Action of the Ligand | Inhibition |
Direct Interaction? | True |
Endogenous Drug? | False |
ENALAPRIL | DrugBank Drug Name |
75847-73-3 | CAS Number |
Acetec | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Groups | vet_approved |
ENALAPRIL | Primary Drug Name |
Year of Approval | 1985 |
Drug Class | antihypertensive agents |
Drug Indications | antihypertensive agent |
Drug Class | Small Molecule |
FDA Approval | approved |
C468 | NCI drug code |
ENALAPRIL | GuideToPharmacology Ligand Name |
D00SEB | TTD Drug ID |
CHEMBL578 | ChEMBL Drug ID |